Out of 317 online pharmacies, about 42% are selling semaglutide illegally, according to a JAMA Network study. These pharmacies sold the product without a prescription and operated without a valid license. As part of the study, researchers purchased the semaglutide products from six online pharmacies that are listed on NABP’s Not Recommended List. These pharmacies sold 0.25 mg per dose semaglutide injection pens and vials of lyophilized semaglutide to be reconstituted to solution for injection. Only three of the vendors sent products; the other three vendors sent fraudulent requests asking for extra payments to clear customs. Quality testing revealed that one of the products contained levels of endotoxin.
NABP encourages health care professionals and consumers purchasing products online to only buy medications from verified, licensed pharmacy websites that comply with applicable laws and NABP patient safety and pharmacy standards. Verify before you buy using the Safe Site Search Tool at safe.pharmacy.